Market Trends– category –
-
Biologics CDMO Market Competitive Landscape Report: Lonza, Samsung Biologics, and WuXi Biologics Drive Growth
National Law Review USA Overview This article summarizes a report on the competitive landscape and growth drivers of the biologics CDMO market. Key players include Lonza Group Ltd, Samsung Biologics Co Ltd, WuXi Biologics Cayman Inc, The... -
U.S. Stem Cell Manufacturing Market Forecast to Reach $4.04 Billion, Driven by Innovative Technologies and Automation from Thermo Fisher, Lonza, and Sartorius
openPR.com USA Overview This article summarizes a report on the U.S. stem cell manufacturing market, projected to reach $4.04 billion, driven by innovative technologies and strategic initiatives from key players. Thermo Fisher Scientific... -
WuXi Biologics Suzhou BioSafety Testing Center Secures Fourth EMA GMP Certification, Enabling 19 Commercial Products for European Market
WuXi Biologics China Overview WuXi Biologics' Suzhou BioSafety Testing Center has successfully renewed its European Medicines Agency (EMA) GMP certification for the fourth time. This accreditation enables the center to support quality te... -
CDMO Signal Ranks Lentiviral Vector (LVV) CDMOs: GMP Standards and Robust Assays Key for Selection
CDMO Signal USA Overview CDMO Signal published its ranking of Lentiviral Vector (LVV) CDMOs based on Signal Score. LVVs are critical in ex vivo gene therapies for engineering CAR-T cells and modifying hematopoietic stem cells, necessitat... -
ORF Genetics Dramatically Cuts Cultivated Meat Production Costs by Producing Growth Factors Using Barley
Farmtario Canada Overview Barley is reported to play a crucial role in cultivated meat production without animal rearing. ORF Genetics developed an innovative technology to produce animal growth factors, essential for cultivated meat cel... -
Cytiva CEO Pierre-Alain Ruffieux Emphasizes Standardization and Automation for Scaling Cell and Gene Therapy Manufacturing Ahead of BIO 2026
BioPharm International USA Overview Ahead of BIO International Convention 2026, Cytiva CEO Pierre-Alain Ruffieux discussed scaling cell and gene therapy (CGT) manufacturing to expand global access. He emphasized standardization and autom... -
Cultivated Meat Institute Envisions Sustainable Future with >99% Media Cost Reduction and Significant Bioreactor Capacity Expansion
Alt Protein Planet USA Overview Dr. Elliot Swartz of the Cultivated Meat Institute reported that the cultivated meat industry has achieved over 99% reduction in media costs and significantly expanded bioreactor capacity over the past dec... -
Miltenyi Biotec’s Global T-Cell Manufacturing Platform Integrates Automated Closed Systems, Cuts Manual Labor by Over 70%, Achieves High Yields
Bioprocess Online Germany Overview Miltenyi Biotec proposes that global scaling of TCR-T cell manufacturing requires a fundamental process redesign, integrating six key production steps into a single automated, closed system. This integr... -
BioPharm International Emphasizes Standardization and Automation for Overcoming Complex Cell & Gene Therapy Manufacturing Challenges
BioPharm International USA Overview BioPharm International highlighted that standardization and automation are critical for navigating the complex landscape of cell and gene therapy (CGT) manufacturing. To improve global patient access t... -
Regulatory Complexity Poses Market Challenges for Cultivated Meat Products: US USDA Approval Amidst Inconsistent State Regulations
PetfoodIndustry USA Overview Regulatory complexity for cell-cultivated meat products poses significant challenges for manufacturers in consumer engagement. While the USDA approved cell-cultivated chicken sales in 2023 and established a r...
